The World Health Organization (WHO) has added two cancer drugs to its 2019 essential medicines list despite oncologists calling for less toxic therapies for the disease.
The two recently developed immunotherapies (nivolumab and pembrolizumab), WHO say, have delivered up to 50 per cent survival rates for advanced melanoma, a cancer that until recently was incurable.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article